COVID-19: Infected Patient Study



COVID-19 CLINICAL TRIAL FOR

COVID-19 INFECTED PATIENTS

Monoclonal Antibody Therapy by REGENERON

This study is for NON-HOSPITALIZED COVID-19 infected patients. The study is single infusion of monoclonal antibody (2 doses) vs Placebo as investigational treatment. Patients will be randomized 1:1:1.

Summary Inclusions for the study are:

  • Age 18 years and over
  • Covid PCR Positive (on-site testing can also confirm within 45 min)
  • One more more of SOB, cough or fever
  • COVID Symptoms for less than 7 days
  • Able to consent

Summary Exclusions for the study are:

  • Hospital admission for COVID
  • IVIG infusion in past 3 months
  • Treatment with Remdesivir
  • Pregnant/Breastfeeding


Sign-up to enroll for this study today!








    Social networks


    Facebook

    www.facebook.com/azclinicaltrials


    Twitter

    @azclintrials


    Instagram

    @azclinicaltrials



    Locations


    Mesa Office

    2152 S Vineyard Ave Ste 123
    Mesa, AZ 85210
    480-360-4000


    Tucson Office

    1601 N Swan Rd
    Tucson, AZ 85712
    520-445-4000


    Call us to see if you or your patient qualify for a clinical trial.